Development of a risk calculator to predict attention-deficit/hyperactivity disorder in very preterm/very low birth weight newbornsJOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRYIF72021-11-222PRE
Assessing undertreatment and overtreatment/misuse of ADHD medications in children and adolescents across continents: A systematic review and meta-analysisNEUROSCIENCE AND BIOBEHAVIORAL REVIEWSIF7.92021-09-0119OAAI
Meta-analysis and systematic review of ADGRL3 (LPHN3) polymorphisms in ADHD susceptibilityMOLECULAR PSYCHIATRYIF10.12020-02-1221OAAI
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studiesCOCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42018-05-10211OAAI
Attention-Deficit/Hyperactivity Disorder and Very Preterm/Very Low Birth Weight: A Meta-analysisPEDIATRICSIF6.42018-01-01212OAAI
BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorderActa Psychiatrica ScandinavicaIF52016-05-2214PREAI
Association Between ADHD and Obesity: A Systematic Review and Meta-AnalysisAMERICAN JOURNAL OF PSYCHIATRYIF14.72016-01-01404OAAI
Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)COCHRANE DATABASE OF SYSTEMATIC REVIEWSIF9.42015-11-25154OA
Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trialsBMJ-BRITISH MEDICAL JOURNALIF42.72015-11-25159OAAI
Attention-deficit/hyperactivity disorder dimensionality: the reliable 'g' and the elusive 's' dimensionsEUROPEAN CHILD & ADOLESCENT PSYCHIATRYIF4.92015-04-1732PREAI
Switching from methylphenidate immediate release to MPH-SODAS™ in attention-deficit/hyperactivity disorderEUROPEAN CHILD & ADOLESCENT PSYCHIATRYIF4.92007-09-103PREAI